RBR-35mp4q
Completed
未知
Study of the role of hydroxychloroquine in immunomodulation and control of hypercoagulability in patients diagnosed with Primary antiphospholipid syndrome
Hemocentro- Universidade Estadual de Campinas0 sitesStarted: January 31, 2020Last updated:
Overview
- Phase
- 未知
- Status
- Completed
- Sponsor
- Hemocentro- Universidade Estadual de Campinas
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Intervention
Eligibility Criteria
- Ages
- 17Y to 65Y (—)
Inclusion Criteria
- •Confirmed diagnosis of primary antiphospholipid syndrome with thrombosis; age between 17 and 65 years old
Exclusion Criteria
- •Diagnosis of active neoplasia; presence of other associated autoimmune diseases; gestational period; antiphospholipid syndrome with isolated obstetric complications
Investigators
Similar Trials
Recruiting
Phase 3
Effect of Hydroxychloroquine in patients with repeated implantation failureIRCT2017060634209N1Shahid Beheshti University of Medical Sciences30
Active, not recruiting
Not Applicable
Evaluation of the efficacy of hydroxychloroquine in decreasing immune activation in asymptomatic HIV-infected patients (HCQ-01) - Hydroxychloroquine studyHIV infectionMedDRA version: 9.1Level: LLTClassification code 10020161Term: HIV infectionEUCTR2007-005057-36-GBMedical Research Council
Completed
Not Applicable
HCQ-01 Trial: evaluation of the efficacy of hydroxychloroquine in decreasing immune activation in asymptomatic human immunodeficiency virus (HIV) infected patientsISRCTN30019040Medical Research Council Clinical Trials Unit (MRC CTU) (UK)90
Completed
Phase 4
A study to compare hydroxychloroquine with aspirin and clopidogrel as an antiplatelet agent.CTRI/2013/03/003485PGIMER20
Completed
Not Applicable
Effect of hydroxychloroquine on recurrent abortion treatmentrecurrent abortion.Spontaneous abortionIRCT2015120910664N2Experimental Medicine Research Centerof Tehran University of Medical Science,Vice chancellor for res60